PDT Partners’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,301
Closed -$212K 760
2022
Q3
$212K Buy
+18,301
New +$251K 0.03% 697
2022
Q2
Sell
-17,699
Closed -$342K 1049
2022
Q1
$342K Hold
17,699
0.03% 681
2021
Q4
$305K Buy
+17,699
New +$302K 0.02% 666
2020
Q4
Sell
-22,901
Closed -$239K 767
2020
Q3
$239K Buy
+22,901
New +$291K 0.02% 592
2020
Q2
Sell
-13,400
Closed -$158K 737
2020
Q1
$158K Buy
+13,400
New +$177K 0.01% 583
2018
Q3
Sell
-305,599
Closed -$4.22M 504
2018
Q2
$4.22M Sell
305,599
-38,824
-11% -$582K 0.16% 168
2018
Q1
$5.74M Buy
344,423
+149
+0% +$2.3K 0.19% 153
2017
Q4
$4.88M Sell
344,274
-84,326
-20% -$1.12M 0.14% 189
2017
Q3
$6.05M Sell
428,600
-42,200
-9% -$558K 0.2% 161
2017
Q2
$6.03M Buy
+470,800
New +$5.91M 0.24% 142
2015
Q4
Sell
-40,650
Closed -$292K 667
2015
Q3
$292K Buy
+40,650
New +$552K 0.01% 1057
2014
Q4
Sell
-213,856
Closed -$3.65M 854
2014
Q3
$3.65M Buy
+213,856
New +$4.91M 0.09% 277
2013
Q4
Sell
-50,378
Closed -$1.66M 883
2013
Q3
$1.66M Sell
50,378
-44,065
-47% -$1.37M 0.05% 569
2013
Q2
$2.93M Buy
+94,443
New +$2.53M 0.07% 376

Other funds holding INVA

PDT Partners's INVA Position: Q4 2022 in Review

PDT Partners sold out of Innoviva (INVA) in Q4 2022, closing a stake of 18,301 shares — an estimated $212K sold.

PDT Partners first reported a position in INVA in Q2 2013 and held it in 14 quarters. The position peaked at $6.05M in Q3 2017. 209 funds tracked by Wall St. Rank hold INVA as of Q4 2022.

  • PDT Partners reported no remaining Innoviva position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 18,301 Innoviva shares in Q4 2022, an estimated $212K.
  • PDT Partners first reported a position in Innoviva in Q2 2013 and held it in 14 quarters.
  • PDT Partners's Innoviva position peaked at $6.05M in Q3 2017.
  • 209 funds tracked by Wall St. Rank held Innoviva as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.